Everjoy Health Group Co.,Ltd. (SHE:002162)

Everjoy Health Group Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	7.52	6.73	-147.12	50.06	-277.84	46.17
Depreciation & Amortization	53.76	54.09	58.33	64.71	71.39	75.48
Other Amortization	11.34	11	10.46	9.42	14.51	9.36
Loss (Gain) From Sale of Assets	1.97	1.97	-	0.26	55.07	6.88
Asset Writedown & Restructuring Costs	0.5	0.5	29.25	24.18	59.92	-20.14
Loss (Gain) From Sale of Investments	-1.46	-1.46	9.29	-162.35	12.96	3.96
Provision & Write-off of Bad Debts	-3.51	-3.51	35.53	57.35	48.84	6.37
Other Operating Activities	12.28	24.21	35.52	66.78	116.54	41.6
Change in Accounts Receivable	74.61	74.61	90.1	-45.67	-65.82	-6
Change in Inventory	11.95	11.95	20.97	48.79	32.96	19.47
Change in Accounts Payable	-107.09	-107.09	-99.65	16.57	-21.15	-27.94
Change in Other Net Operating Assets	-2.08	-2.08	1.02	2.76	-	-
Operating Cash Flow	62.92	74.05	82.23	123.62	25.88	153.24
Operating Cash Flow Growth	-22.13%	-9.95%	-33.48%	377.71%	-83.11%	0.52%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-15.63	-41.88	-31.62	-49.52	-39.5	-34.16
Sale of Property, Plant & Equipment	7.72	5.03	0	20.74	6.77	10.88
Cash Acquisitions	3.46	-	-	-	-	-
Divestitures	67.55	46.66	39.37	86.58	-	1.47
Investment in Securities	-21.86	-26.29	-22.08	12.1	-58.52	-40.92
Other Investing Activities	-0.92	6.8	5.27	10.49	7.48	5.98
Investing Cash Flow	40.33	-9.68	-9.06	80.39	-83.78	-56.75

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Long-Term Debt Issued	-	332.68	339.54	320	743.75	449.12
Long-Term Debt Repaid	-	-379.05	-377.31	-464.48	-723.92	-585.53
Net Debt Issued (Repaid)	31.22	-46.37	-37.77	-144.48	19.84	-136.41
Issuance of Common Stock	-	5.6	1.58	-	-	197.89
Repurchase of Common Stock	-4.5	-10	-25.19	-	-	-
Common Dividends Paid	-17.38	-19.75	-23.72	-24.51	-23.62	-29.42
Other Financing Activities	8.25	43.96	-57.96	39.33	-46.87	-37.86
Financing Cash Flow	17.59	-26.56	-143.06	-129.66	-50.65	-5.78

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-0.01	-0.01	0	0.02	0.11	-0.05
Net Cash Flow	120.84	37.8	-69.89	74.36	-108.44	90.66

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	47.3	32.17	50.61	74.1	-13.63	119.09
Free Cash Flow Growth	18.83%	-36.43%	-31.70%	-	-	-3.52%
Free Cash Flow Margin	4.46%	3.03%	4.20%	5.80%	-1.17%	9.45%
Free Cash Flow Per Share	0.05	0.04	0.06	0.08	-0.01	0.13
Levered Free Cash Flow	42.84	-45.69	20.96	54.08	103.35	-21.88
Unlevered Free Cash Flow	46.28	-32.04	35.89	70.98	122.13	-0.53

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Interest Paid	0.37	0.59	1	0.7	0.8	2.95
Cash Income Tax Paid	47.16	36.48	42.28	74.35	47.83	71.72
Change in Working Capital	-19.48	-19.48	50.97	13.2	-75.5	-16.44

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error